Not Signed In -
Cyclophosphamide |
CTX; Cytoxan |
Cyclophosphamide Systematic (IUPAC) name N,N-bis(2-chloroethyl)-2-oxo-1-oxa-3-aza -2u{5}-phosphacyclohexan-2-amine Identifiers CAS number 50-18-0 ATC code L01AA01 PubChem 2907 DrugBank APRD00408 Chemical data Formula C7H15N2Cl2O2P Mol. weight 261.085 g/mol SMILES C1CNP(=O)(OC1)N(CCCl)CCCl Physical data Melt. point 2°C (36°F) Pharmacokinetic data Bioavailability >75% (oral) Protein binding >60% Metabolism Hepatic Half life 3-12 hours ...
Wikipedia - [full article]
Cyclophosphamide Clinical Trials
- A Three Arm Study of Adriamycin, Cyclophosphamide Plus Docetaxel vs Adriamycin Plus Cyclophosphamide Followed By Paclitaxel vs Adriamycin Plus Cyclophosphamide Followed By Paclitaxel and Gemcitabine in Adjuvant Breast Cancer
ClinicalTrials.gov Identifier: NCT00191958 - Active, not recruiting
Breast Neoplasms
- Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus
ClinicalTrials.gov Identifier: NCT00010413 - Active, not recruiting
Pemphigus
- Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Immunodeficiency or Noncancerous Inherited Disorders
ClinicalTrials.gov Identifier: NCT00358657 - Recruiting
Precancerous/Nonmalignant Condition
- Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002653 - Active, not recruiting
Multiple Myeloma
- High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide
ClinicalTrials.gov Identifier: NCT00005778 - Active, not recruiting
Lupus Erythematosus, Systemic
- High-Dose Total-Body Irradiation, Cyclophosphamide, Antithymocyte Globulin, and Autologous Stem Cell Transplant or High-Dose Cyclophosphamide in Treating Patients With Severe Systemic Sclerosis
ClinicalTrials.gov Identifier: NCT00545038 - Recruiting
Precancerous/Nonmalignant Condition
- Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00002482 - Active, not recruiting
Lymphoma; Leukemia; Multiple Myeloma
- Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors
ClinicalTrials.gov Identifier: NCT00003288 - Active, not recruiting
unspecified childhood solid tumor, protocol specific
- Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00258960 - Recruiting
Breast Cancer
- Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis
ClinicalTrials.gov Identifier: NCT00016458 - Active, not recruiting
Systemic Sclerosis
- Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00002953 - Active, not recruiting
stage IV breast cancer
- Phase III Randomized Study of Cyclophosphamide with or without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients with Aplastic Anemia
ClinicalTrials.gov Identifier: NCT00004474 - Active, not recruiting
Aplastic Anemia
- Study of High Dose Cyclophosphamide in Patients with Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
ClinicalTrials.gov Identifier: NCT00004464 - Active, not recruiting
Aplastic Anemia; Paroxysmal Hemoglobinuria, Nocturnal
- Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone OR Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Rituximab Followed by Vaccine Therapy Plus Sargramostim in Treating Patients With Stage II, Stage III, or Stage IV Follicular Lymphoma
ClinicalTrials.gov Identifier: NCT00019981 - Recruiting
Lymphoma
- Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
ClinicalTrials.gov Identifier: NCT00010387 - Active, not recruiting
Anemia, Hemolytic, Autoimmune; Felty Syndrome; Purpura, Thrombocytopenic; Autoimmune Diseases
- Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00138229 - Active, not recruiting
Recurrent Melanoma; Stage IV Melanoma
- Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00083031 - Active, not recruiting
recurrent breast cancer; stage IV breast cancer
- Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00148317 - Recruiting
Multiple Myeloma
- Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00024440 - Active, not recruiting
refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
- Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma
ClinicalTrials.gov Identifier: NCT00074178 - Active, not recruiting
primary central nervous system lymphoma; intraocular lymphoma
- Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00107276 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Cyclophosphamide With or Without Rituximab and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00028665 - Active, not recruiting
adult non-Hodgkin's lymphoma
- Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
ClinicalTrials.gov Identifier: NCT00004067 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer
- Bevacizumab with Or Without Cyclophosphamide and Methotrexate: a Pilot Study in Women with Operable Breast Cancer
ClinicalTrials.gov Identifier: NCT00121134 - Recruiting
Breast Cancer
- Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00004175 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer
- Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) With or Without ImmTher for Newly Diagnosed High Risk Ewing's Sarcoma
ClinicalTrials.gov Identifier: NCT00038142 - Recruiting
Ewing's Sarcoma
- Cyclophosphamide and Celecoxib in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00551889 - Active, not recruiting
Unspecified Adult Solid Tumor, Protocol Specific
- Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers
ClinicalTrials.gov Identifier: NCT00003658 - Active, not recruiting
adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma
- Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003870 - Active, not recruiting
adult acute lymphoblastic leukemia in remission; recurrent adult acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia; ...
- Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Lymphoma
ClinicalTrials.gov Identifier: NCT00006252 - Active, not recruiting
adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia
- Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00079261 - Active, not recruiting
adult diffuse large cell lymphoma; adult lymphomatoid granulomatosis; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; ...
- Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00002475 - Active, not recruiting
Breast Cancer; Colorectal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer; pleura cancer
- Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00006042 - Active, not recruiting
childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ...
- Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women With Early Breast Cancer
ClinicalTrials.gov Identifier: NCT00070278 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00276848 - Active, not recruiting
Leukemia
- Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00281931 - Active, not recruiting
Leukemia
- Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00343447 - Active, not recruiting
Leukemia
- A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients
ClinicalTrials.gov Identifier: NCT00190671 - Active, not recruiting
Breast Neoplasms
- Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00281918 - Active, not recruiting
Leukemia
- Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00005866 - Active, not recruiting
untreated adult acute myeloid leukemia; secondary myelodysplastic syndrome; de novo myelodysplastic syndrome; ...
- Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003659 - Active, not recruiting
stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia
- Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia
ClinicalTrials.gov Identifier: NCT00445900 - Active, not recruiting
Chronic Myeloproliferative Disorders; Secondary Myelofibrosis
- Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases
ClinicalTrials.gov Identifier: NCT00317785 - Active, not recruiting
Leukemia; Lymphoma; Myelodysplastic Syndromes
- Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00016406 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer
- Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00085423 - Recruiting
Recurrent Melanoma; Stage IV Melanoma
- Phase II Study to Evaluate the Combination of Fludarabine, Cyclophosphamide, and Alemtuzumab in Patients with B-CLL
ClinicalTrials.gov Identifier: NCT00147901 - Recruiting
B-cell Chronic Lymphocytic Leukemia
- Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00062036 - Active, not recruiting
Melanoma (Skin)
- Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer
ClinicalTrials.gov Identifier: NCT00525642 - Active, not recruiting
Breast Neoplasms; Adjuvant; Chemotherapy
- Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
ClinicalTrials.gov Identifier: NCT00562978 - Active, not recruiting
Lymphoma
- Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00275015 - Active, not recruiting
Leukemia
- Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00281983 - Active, not recruiting
Leukemia; Lymphoma
- Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00073879 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00072319 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; ...
- Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00091104 - Active, not recruiting
Melanoma (Skin)
- Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00074139 - Active, not recruiting
stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
ClinicalTrials.gov Identifier: NCT00066469 - Recruiting
post-transplant lymphoproliferative disorder
- Chemotherapy in Treating Patients With Retinoblastoma
ClinicalTrials.gov Identifier: NCT00002675 - Active, not recruiting
Retinoblastoma
- Chemotherapy Consisting of Fludarabine and Cyclophosphamide Followed By White Blood Cell Infusion, Vaccine Therapy, and Aldesleukin in Treating Patients With Recurrent or Refractory Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00084500 - Active, not recruiting
Melanoma (Skin)
- Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00096382 - Active, not recruiting
Melanoma (Skin)
- Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00003868 - Active, not recruiting
adult acute myeloid leukemia; childhood acute myeloid leukemia; secondary acute myeloid leukemia
- Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003764 - Active, not recruiting
stage 0 chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
- Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer
ClinicalTrials.gov Identifier: NCT00193115 - Active, not recruiting
Breast Cancer
- Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer
ClinicalTrials.gov Identifier: NCT00201708 - Active, not recruiting
Breast Cancer
- Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00002576 - Active, not recruiting
Lymphoma
- OCSTUD Docetaxel+Cisplatin+Cyclophosphamide Versus Docetaxel+Carboplatin in Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00452985 - Active, not recruiting
Ovarian Neoplasms
- Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00004114 - Active, not recruiting
Leukemia; Lymphoma
- Chemotherapy and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00002547 - Active, not recruiting
Leukemia
- Bone Marrow Transplantation Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00002809 - Active, not recruiting
Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; atypical chronic myeloid leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; ...
- Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00004036 - Active, not recruiting
Cancer
- Treatment of Patients with Idiopathic Membranous Nephropathy
ClinicalTrials.gov Identifier: NCT00135954 - Active, not recruiting
Glomerulonephritis, Membranous
- Phase I Study of High-Dose Cyclophosphamide, Anti-Thymocyte Globulin, and Total Body Irradiation With T-Cell-Depleted Autologous Bone Marrow Rescue in Patients With High-Risk Rheumatoid Arthritis
ClinicalTrials.gov Identifier: NCT00017615 - Recruiting
Rheumatoid Arthritis; Juvenile Rheumatoid Arthritis
- Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
ClinicalTrials.gov Identifier: NCT00003549 - Active, not recruiting
neuroendocrine carcinoma of the skin
- Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
ClinicalTrials.gov Identifier: NCT00436709 - Active, not recruiting
Breast Cancer
- A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00190489 - Active, not recruiting
Breast Cancer; Neoplasm Metastasis
- Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00080847 - Active, not recruiting
contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ...
- Rituximab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With Relapsed Hodgkin''s Lymphoma
ClinicalTrials.gov Identifier: NCT00134082 - Recruiting
recurrent adult Hodgkin''s lymphoma
- Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer
ClinicalTrials.gov Identifier: NCT00544765 - Active, not recruiting
Breast Cancer
- VELCADE®, Rituximab, Cyclophosphamide, and Decadron (VRCD Regimen)
ClinicalTrials.gov Identifier: NCT00413959 - Recruiting
NHL
- Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders
ClinicalTrials.gov Identifier: NCT00010335 - Recruiting
Systemic Sclerosis; Systemic Lupus Erythematosus; Dermatomyositis; Juvenile Rheumatoid Arthritis; Autoimmune Diseases
- Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00364754 - Active, not recruiting
Metastatic/Recurrent Breast Cancer
- Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00070447 - Active, not recruiting
contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; stage IV mantle cell lymphoma
- Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00093834 - Recruiting
stage IV breast cancer; recurrent breast cancer
- Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Patients With Neuroblastoma
ClinicalTrials.gov Identifier: NCT00033293 - Recruiting
localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
- Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003397 - Active, not recruiting
Lymphoma
- Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00004898 - Active, not recruiting
Leukemia; Lymphoma
- Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma
ClinicalTrials.gov Identifier: NCT00245089 - Recruiting
Sarcoma
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma
ClinicalTrials.gov Identifier: NCT00002740 - Active, not recruiting
disseminated neuroblastoma
- Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00002501 - Active, not recruiting
stage IV grade II follicular mixed cell lymphoma; recurrent grade I follicular small cleaved cell lymphoma; ...
- Therapy with Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients with Breast Cancer
ClinicalTrials.gov Identifier: NCT00110695 - Active, not recruiting
Breast Neoplasms
- Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00201721 - Active, not recruiting
B-Chronic Lymphocytic Leukemia
- Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients
ClinicalTrials.gov Identifier: NCT00410163 - Recruiting
B-Cell Chronic Lymphocytic Leukemia
- Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00242996 - Active, not recruiting
Lymphoma
- Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00002471 - Active, not recruiting
Lymphoma; Leukemia
- Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003402 - Active, not recruiting
Lymphocytic Lymphoma
- Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00003398 - Active, not recruiting
Lymphoma; Leukemia; Multiple Myeloma
- Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00003396 - Active, not recruiting
Lymphoma; Leukemia; Multiple Myeloma
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma
ClinicalTrials.gov Identifier: NCT00245141 - Recruiting
Sarcoma
- Fludarabine Plus Cyclophosphamide Followed by Zevalin in Non-Follicular Indolent Lymphomas Refractory or Relapsed
ClinicalTrials.gov Identifier: NCT00354822 - Recruiting
Lymphoma, Non-Hodgkin
- Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants with Brain Tumors
ClinicalTrials.gov Identifier: NCT00042367 - Active, not recruiting
Brain Tumors
- Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma
ClinicalTrials.gov Identifier: NCT00003187 - Active, not recruiting
Lymphoma; Leukemia
Resources
- CTX (Drug Digest)
- Cyclophosphamide (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
